All Blogs

Dec 27, 2024

Sickle cell disease is a hereditary blood disorder marked by abnormal hemoglobin, which leads to the deformation of red blood cells into a sickle shape. It is a major global health issue, especially common in individuals of African, Middle Eastern, Mediterranean, and South Asian descent. Based on DelveInsight's ...

Jan 01, 2025

Medical drones are revolutionizing healthcare by delivering critical supplies, medicines, and even organ transplants to remote or underserved areas, often in record time. These high-tech flying lifelines bridge the gap in emergency care, ensuring that vital resources reach patients who need them most, regardless of...

Dec 25, 2024

In the rapidly evolving healthcare sector, technology plays a pivotal role in transforming patient care, improving operational efficiency, and enhancing overall healthcare delivery. One of the most impactful advancements is the integration of healthcare mobility solutions.  From mobile health (mHealth) apps...

Dec 23, 2024

Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can affect multiple parts of the body. In 2023, it was estimated that around 500,000 individuals in the United States were living with SLE, as per DelveInsight analysis. The prevalence is significantly higher in females, who account for over ...

Dec 20, 2024

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally, according to the World Health Organization (WHO). It affects approximately 251 million people worldwide. Smoking is the leading cause of COPD, responsible for around 70-90% of cases. However, exposure to air pollution, occupa...

Dec 19, 2024

Siemens Healthineers Acquired Novartis’s Advanced Accelerator Applications Molecular Imaging  On December 10, 2024, Siemens Healthineers completed the acquisition of Advanced Accelerator Applications Molecular Imaging from Novartis. This European manufacturing and distribution network specializes in diagnos...

Dec 18, 2024

Access to healthcare is a fundamental human right, yet millions of people around the world face significant barriers to receiving timely and effective medical attention. Whether due to geographic isolation, economic disparities, or a shortage of healthcare facilities, these barriers can lead to worsening health out...

Dec 17, 2024

Neurocrine Announces FDA Approval of CRENESSITY for Congenital Adrenal Hyperplasia Neurocrine Biosciences, Inc. announced that the FDA has approved CRENESSITY™ (crinecerfont) as an adjunctive treatment to glucocorticoid replacement for controlling androgens in adult and pediatric patients aged four years and old...

Dec 16, 2024

Merus had a standout start this month. Shortly after landing a long-anticipated commercialization partner for its zenocutuzumab, the drug has achieved FDA approval, becoming the first therapy to target cancers with a neuregulin 1 (NRG1) gene fusion. The FDA granted accelerated approval to the drug, now marketed ...

Dec 13, 2024

AstraZeneca has secured another approval for its cancer blockbuster IMFINZI (durvalumab), as the FDA has approved the PD-L1 inhibitor for patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following concurrent chemotherapy and radiation. This approval makes IMFINZI the ...